Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1987 1
1990 1
1992 1
1993 1
1994 4
1995 1
1996 1
1998 1
1999 1
2000 4
2001 3
2002 4
2003 1
2004 2
2005 5
2006 5
2007 2
2008 8
2009 5
2010 3
2011 9
2012 7
2013 8
2014 13
2015 10
2016 7
2017 10
2018 9
2019 5
2020 10
2021 15
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

141 results
Results by year
Filters applied: . Clear all
Page 1
Advances in personalized cancer immunotherapy.
Kakimi K, Karasaki T, Matsushita H, Sugie T. Kakimi K, et al. Breast Cancer. 2017 Jan;24(1):16-24. doi: 10.1007/s12282-016-0688-1. Epub 2016 Mar 21. Breast Cancer. 2017. PMID: 27000871 Review.
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy.
Nagaoka K, Shirai M, Taniguchi K, Hosoi A, Sun C, Kobayashi Y, Maejima K, Fujita M, Nakagawa H, Nomura S, Kakimi K. Nagaoka K, et al. Among authors: kakimi k. J Immunother Cancer. 2020 Oct;8(2):e001358. doi: 10.1136/jitc-2020-001358. J Immunother Cancer. 2020. PMID: 33093158 Free PMC article.
[Neoantigens and Whole-Exome Sequencing].
Karasaki T, Nakajima J, Kakimi K. Karasaki T, et al. Among authors: kakimi k. Gan To Kagaku Ryoho. 2016 Jul;43(7):791-7. Gan To Kagaku Ryoho. 2016. PMID: 27431622 Review. Japanese.
γδ T-cell immunotherapy for lung cancer.
Yoshida Y, Nakajima J, Wada H, Kakimi K. Yoshida Y, et al. Among authors: kakimi k. Surg Today. 2011 May;41(5):606-11. doi: 10.1007/s00595-010-4478-7. Epub 2011 May 1. Surg Today. 2011. PMID: 21533930 Review.
[γδ T cell-based cancer immunotherapy].
Matsushita H, Kakimi K. Matsushita H, et al. Among authors: kakimi k. Nihon Rinsho. 2017 Feb;75(2):301-305. Nihon Rinsho. 2017. PMID: 30562868 Japanese.
Exploring immune therapy for renal cancer.
Matsushita H, Kakimi K, Tomita Y, Tatsugami K, Naito S, Suekane S, Noguchi M, Moriya F, Matsuoka K, Itoh K, Kobayashi H, Eto M, Takahashi W, Kawano Y, Wada Y. Matsushita H, et al. Among authors: kakimi k. Int J Urol. 2011 Jun;18(6):412-21. doi: 10.1111/j.1442-2042.2011.02762.x. Int J Urol. 2011. PMID: 21599759 No abstract available.
[Dendritic cells for cancer immunotherapy].
Kakimi K, Kondo A, Matsushita H. Kakimi K, et al. Nihon Rinsho. 2012 Dec;70(12):2130-5. Nihon Rinsho. 2012. PMID: 23259385 Review. Japanese.
Tumor Growth Suppression With Novel Intra-arterial Chemotherapy Using Epirubicin-entrapped Water-in-oil-in-water Emulsion In Vivo.
Yanagie H, Fujino T, Yanagawa M, Terao T, Imagawa T, Fujihara M, Morishita Y, Mizumachi R, Murata Y, Dewi N, Ono Y, Ikushima I, Seguchi K, Nagata M, Nonaka Y, Furuya Y, Hisa T, Nagasaki T, Arimori K, Nakashima T, Sugihara T, Kakimi K, Ono M, Nakajima J, Eriguchi M, Higashi S, Takahashi H. Yanagie H, et al. Among authors: kakimi k. In Vivo. 2021 Jan-Feb;35(1):239-248. doi: 10.21873/invivo.12252. In Vivo. 2021. PMID: 33402470 Free PMC article.
141 results